Bulevirtide is the only approved antiviral drug against hepatitis delta.
Clinical Trials
Posted inClinical Trials, In the Pipeline, Metabolism
Most Effective Weight Loss Drugs: Present and Future
Modern pharmacological ways to combat obesity.
Posted inClinical Trials, Neuroscience, Rare/Orphan Diseases
Alsitek: New Drug for ALS
Oral masitinib doubles the life in patients with amyotrophic lateral sclerosis.
Posted inClinical Trials, Infections, Rare/Orphan Diseases
Olorofim: New Antifungal Drug
Olorophim by F2G and Shionogi & Co. is focused on invasive aspergillosis treatment.
Posted inClinical Trials, Metabolism
Tirzepatide: Strong Weight-Loss Drug
Losing 24 kilograms in a year and a half.
Posted inAutoimmune Diseases, Clinical Trials, Neuroscience
Ublyxi: Highly Effective Drug for Multiple Sclerosis
Ublituximab is the third anti-CD20 therapy for multiple sclerosis and a worthy rival to Ocrevus and Kesimpta.
Posted inClinical Trials, Infections
Ycanth: First Treatment for Molluscum Contagiosum and Warts
Cantharidin Verrica Pharmaceuticals can help get rid of common viral skin lesions.